Henry Schein, Inc. (NASDAQ:HSIC) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.

Henry Schein Inc. closed 10.96% short of its 52-week high of $82.49, which the company reached on February 5th.

The 4 dental equipment & technology stocks we track reported a strong Q1. As a group, revenues beat analysts’ consensus estimates by 0.7% while next quarter’s revenue guidance was in line.

Henry Schein currently trades 11.8% below its 52-week high of $82.49 recorded on Feb. 5. HSIC's stock has gained 4.9% over the past three months, outpacing the broader Dow Jones Industrial Average ...

Henry Schein, Inc.’s HSIC joint venture, Henry Schein One, is driving strong growth in its core products and introducing new solutions. The company’s robust acquisition strategy helps it to pursue ...

Henry Schein, Inc. (NASDAQ:HSIC) is one of the 13 Cheap Mid-Cap Stocks to Add to Your Portfolio. On June 16, Leerink Partners analyst Michael Cherny maintained a Hold rating on Henry Schein, Inc.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Melville, New York-based dental supply distributor Henry Schein, Inc. announced April 6 that it has completed its acquisition of a majority ownership stake of Biotech Dental S.A.S., a provider of ...

Henry Schein Dental UK | 7,785 followers on LinkedIn. Rely on Us | Follow Us To Hear About… - The latest news and statistics in the dental industry at your fingertips - Our latest company news ...